Hormonal effects on drug metabolism through the CYP system: Perspectives on their potential significance in the era of pharmacogenomics

Current Drug Targets: Immune, Endocrine and Metabolic Disorders

Volumn 5, Issue 4, 2005, Pages 439-448

  Sarlis, N J ^a   Gourgiotis, L ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Cytochrome; Diabetes; Drug metabolism; Endocrine; Glucocorticoid; Inflammation; Obesity; Pregnancy; Thyroid

Indexed keywords

ALDOSTERONE; AMITRIPTYLINE; BISOPROLOL; CAFFEINE; CARVEDILOL; CHLORPROMAZINE; CLOMIPRAMINE; CLOPIDOGREL; CLOZAPINE; CODEINE; CYCLOPHOSPHAMIDE; CYTOCHROME P450; CYTOCHROME P450 1A2; CYTOCHROME P450 2C19; CYTOCHROME P450 2D6; CYTOCHROME P450 3A4; CYTOCHROME P450 3A5; CYTOCHROME P450 3A7; CYTOKINE; DIAZEPAM; DOXORUBICIN; DRUG METABOLIZING ENZYME; GLUCOCORTICOID; GROWTH HORMONE; ICOSANOID; LINDANE; PARACETAMOL; THYROID HORMONE; TRIAZOLAM; UNINDEXED DRUG;

ADRENERGIC SYSTEM; DIABETES MELLITUS; DRUG BLOOD LEVEL; DRUG EXCRETION; DRUG METABOLISM; EXTRACELLULAR SPACE; GENE EXPRESSION REGULATION; GROWTH HORMONE DEFICIENCY; HOMEOSTASIS; HORMONAL REGULATION; HORMONE ACTION; HORMONE BLOOD LEVEL; HUMAN; IN VITRO STUDY; INFLAMMATION; LIVER; MALNUTRITION; NONHUMAN; OBESITY; OSMOLALITY; PHARMACOGENOMICS; PREGNANCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; TISSUE DISTRIBUTION;

ANIMALS; CYTOCHROME P-450 ENZYME SYSTEM; HORMONES; HUMANS; LIVER; METABOLIC DETOXICATION, DRUG; PHARMACOGENETICS;

EID: 28444491464     PISSN: 15680088     EISSN: None     Source Type: Journal    
DOI: 10.2174/156800805774912971     Document Type: Review

References (108)

1. Meisel, C.; Gerloff, T.; Kirchheiner, J.; Mrozikiewicz, P.M.; Niewinski, P.; Brockmoller, J. and Roots, I. (2003) J. Mol. Med., 81(3), 154-167.
2. Krishna, D.R. and Klotz, U. (1994) Clin. Pharmacokinet., 26(2), 144-160.
3. Nebert, D.W. and Russell, D.W. (2002) Lancet, 360(9340), 1155-1162.
4. Rogers, J.F.; Nafziger, A.N. and Bertino, J.S. Jr. (2002) Am. J. Med., 113(9), 746-750.
5. Shimada, T.; Yamazaki, H.; Mimura, M.; Inui, Y. and Guengerich, F.P. (1994) J. Pharmacol. Exp. Ther., 270(1), 414-423.
6. Ingelman-Sundberg, M. (2002) Toxicology, 181-182, 447-452.
7. Katzung, B.G. (2004). In: Basic and Clinical Pharmacology-Chapters 3 and 4, Appleton-Lange/McGraw-Hill Publishers, New York.
8. Oinonen, T. and Lindros, K.O. (1998) Biochem. J., 329 (Pt 1), 17-35.
9. Cheng, P.Y. and Morgan, E.T. (2001) Curr. Drug Metab., 2(2), 165-183.
10. Morgan, E.T. (1997) Drug Metab. Rev., 29(4), 1129-1188.
11. Liddle, C.; Goodwin, B.J.; George, J.; Tapner, M. and Farrell, G.C. (1998) J. Clin. Endocrinol. Metab., 83(7), 2411-2416.
12. Badger, D.; Kraner, J.; Fraser, D.; Hoglen, N.; Halpert, J. and Sipes, I.G. (1998) Life Sci., 63(25), 367-372.
13. Andersson, U.; Yang, Y.Z.; Bjorkhem, I.; Einarsson, C.; Eggertsen, G. and Gafvels, M. (1999) Biochim. Biophys. Acta, 1438(2), 167-174.
14. Peng, H.M. and Coon, M. J. (1998) Mol. Pharmacol., 54(4), 740-747.
15. Colombo, A.; Bonfanti, P.; Orsi, F. and Camatini, M. (2003) Aquat. Toxicol., 63(2), 173-186.
16. Feely, J. (1983) Clin. Pharmacokinet., 8(1), 1-16.
17. Lebrun-Vignes, B.; Archer, V.C.; Diquet, B.; Levron, J.C.; Chosidow, O.; Puech, A.J. and Warot, D. (2001) Br. J. Clin. Pharmacol., 51(5), 443-450.
18. Morgan, E.T.; MacGeoch, C. and Gustafsson, J.A. (1985) J. Biol. Chem., 260(22), 11895-11898.
19. Pichard, L.; Fabre, I.; Fabre, G.; Domergue, J.; Saint Aubert, B.; Mourad, G. and Maurel, P. (1990) Drug Metab. Dispos., 18(5), 595-606.
20. Pichard, L.; Fabre, I.; Daujat, M.; Domergue, J.; Joyeux, H. and Maurel, P. (1992) Mol. Pharmacol., 41(6), 1047-1055.
21. Sidhu, J.S. and Omiecinski, C.J. (1995) Pharmacogenetics, 5(1), 24-36.
22. Gerbal-Chaloin, S.; Pascussi, J.M.; Pichard-Garcia, L.; Daujat, M.; Waechter, F.; Fabre, J.M.; Carrere, N. and Maurel, P. (2001) Drug Metab. Dispos., 29(3), 242-251.
23. Murray, M. (2000) Hum. Exp. Toxicol., 19(2), 126-131.
24. Huss, J.M. and Kasper, C. B. (2000) Mol. Pharmacol., 58(1), 48-57.
25. Gerbal-Chaloin, S.; Daujat, M.; Pascussi, J.M.; Pichard-Garcia, L.; Vilarem, M. J. and Maurel, P. (2002) J. Biol. Chem., 277(1), 209-217.
26. Pascussi, J.M.; Drocourt, L.; Gerbal-Chaloin, S.; Fabre, J.M.; Maurel, P. and Vilarem, M.J. (2001) Eur. J. Biochem., 268(24), 6346-6358.
27. Simons, S.S. Jr.; Oshima, H. and Szapary, D. (1992) Mol. Endocrinol., 6(7), 995-1002.
28. Watkins, P.B.; Murray, S.A.; Winkelman, L.G.; Heuman, D.M.; Wrighton, S. A. and Guzelian, P.S. (1989) J. Clin. Invest., 83(2), 688-697.
29. Villikka, K.; Kivisto, K.T. and Neuvonen, P.J. (1998) Pharmacol. Toxicol., 83(3), 135-138.
30. McCune, J.S.; Hawke, R.L.; LeCluyse, E.L.; Gillenwater, H.H.; Hamilton, G.; Ritchie, J. and Lindley, C. (2000) Clin. Pharmacol. Ther., 68(4), 356-366.
31. Villikka, K.; Varis, T.; Backman, J.T.; Neuvonen, P.J. and Kivisto, K.T. (2001) Eur. J. Clin. Pharmacol., 57(6-7), 457-460.
32. Oropeza-Hernandez, L.F.; Sierra-Santoyo, A.; Cebrian, M.E.; Manno, M. and Albores, A. (2001) Toxicol. Lett., 124(1-3), 91-99.
33. Balogh, A.; Klinger, G.; Henschel, L.; Borner, A.; Vollanth, R. and Kuhnz, W. (1995) Eur. J. Clin. Pharmacol., 48(2), 161-166.
34. Pollock, B.G.; Wylie, M.; Stack, J.A.; Sorisio, D.A.; Thompson, D.S.; Kirshner, M.A.; Folan, M.M. and Condifer, K. A. (1999) J. Clin. Pharmacol., 39(9), 936-940.
35. Zaigler, M.; Rietbrock, S.; Szymanski, J.; Dericks-Tan, J.S.; Staib, A.H. and Fuhr, U. (2000) Int. J. Clin. Pharmacol. Ther., 38(5), 235-244.
36. Scavone, J.M.; Greenblatt, D.J.; Abernethy, D.R.; Luna, B.G.; Harmatz, J.S. and Shader, R.I. (1997) J. Clin. Pharmacol., 37(5), 437-441.
37. Scavone, J.M.; Greenblatt, D.J. and Blyden, G.T. (1988) J. Clin. Pharmacol., 28(5), 463-466.
38. Sharer, J.E. and Wrighton, S.A. (1996) Drug Metab. Dispos., 24(4), 487-494.
39. Laine, K.; Palovaara, S.; Tapanainen, P. and Manninen, P. (1999) Clin. Pharmacol. Ther., 66(6), 602-608.
40. Slayter, K.L.; Ludwig, E.A.; Lew, K.H.; Middleton, E., Jr.; Ferry, J.J. and Jusko, W.J. (1996) Clin. Pharmacol. Ther., 59(3), 312-321.
41. Stoehr, G.P.; Kroboth, P.D.; Juhl, R.P.; Wender, D.B.; Phillips, J.P. and Smith, R.B. (1984) Clin. Pharmacol. Ther., 36(5), 683-690.
42. Laine, K.; Tybring, G. and Bertilsson, L. (2000) Clin. Pharmacol. Ther., 68(2), 151-159.
43. Hagg, S.; Spigset, O. and Dahlqvist, R. (2001) Br. J. Clin. Pharmacol., 51(2), 169-173.
44. Palovaara, S.; Pelkonen, O.; Uusitalo, J.; Lundgren, S. and Laine, K. (2003) Clin. Pharmacol. Ther., 74(4), 326-333.
45. Guengerich, F.P. (1990) Chem. Res. Toxicol., 3(4), 363-371.
46. Gorski, J.C.; Wang, Z.; Haehner-Daniels, B.D.; Wrighton, S.A. and Hall, S.D. (2000) Clin. Pharmacol. Ther., 68(4), 412-417.
47. Belle, D.J.; Callaghan, J.T.; Gorski, J.C.; Maya, J.F.; Mousa, O.; Wrighton, S. A. and Hall, S. D. (2002) Br. J. Clin. Pharmacol., 53(1), 67-74.
48. Harris, R.Z.; Tsunoda, S.M.; Mroczkowski, P.; Wong, H. and Benet, L.Z. (1996) Clin. Pharmacol. Ther., 59(4), 429-435.
49. Heikkinen, T.; Ekblad, U.; Kero, P.; Ekblad, S. and Laine, K. (2002) Clin. Pharmacol. Ther., 72(2), 184-191.
50. Heikkinen, T.; Ekblad, U.; Palo, P. and Laine, K. (2003) Clin. Pharmacol. Ther., 73(4), 330-337.
51. Wadelius, M.; Darj, E.; Frenne, G. and Rane, A. (1997) Clin. Pharmacol. Ther., 62(4), 400-407.
52. Ejiri, N.; Katayama, K.I.; Nakayama, H. and Doi, K. (2001) Exp. Toxicol. Pathol., 53(5), 387-391.
53. Pasanen, M.; Helin-Martikainen, H.L.; Pelkonen, O. and Kirkinen, P. (1997) Placenta, 18(1), 37-41.
54. Rasmussen, E.; Ask, B.; Finnstrom, N.; Skottner-Lundin, A. and Rane, A. (1998) Biochem. Pharmacol., 56(4), 459-466.
55. Waxman, D.J.; Ram, P.A.; Pampori, N.A. and Shapiro, B.H. (1995) Mol. Pharmacol., 48(5), 790-797.
56. Levitsky, L.L.; Schoeller, D.A.; Lambert, G.H. and Edidin, D.V. (1989) Dev. Pharmacol. Aer., 12(2), 90-95.
57. Rhodes, C.J. and White, M.F. (2002) Eur. J. Clin. Invest., 32(Suppl 3), 3-13.
58. Cheung, N.W.; Liddle, C.; Coverdale, S.; Lou, J.C. and Boyages, S.C. (1996) J. Clin. Endocrinol. Metab., 81(5), 1999-2001.
59. Jurgens, G.; Lange, K.H.; Reuther, L.O.; Rasmussen, B.B.; Brosen, K. and Christensen, H.R. (2002) Clin. Pharmacol. Ther., 71(3), 162-168.
60. Gil Berglund, E.; Johannsson, G.; Beck, O.; Bengtsson, B.A. and Rane, A. (2002) Eur. J. Clin. Invest., 32(7), 507-512.
61. Woodcroft, K.J. and Novak, R.F. (1999) J. Pharmacol. Exp. Aer., 289(2), 1121-1127.
62. Iber, H.; Li-Masters, T.; Chen, Q.; Yu, S. and Morgan, E.T. (2001) J. Pharmacol. Exp. Ther., 297(1), 174-180.
63. Favreau, L.V. and Schenkman, J.B. (1988) Diabetes, 37(5), 577-584.
64. Dong, Z.G.; Hong, J.Y.; Ma, Q.A.; Li, D.C.; Bullock, J.; Gonzalez, F.J.; Park, S.S.; Gelboin, H.V. and Yang, C. S. (1988) Arch. Biochem. Biophys., 263(1), 29-35.
65. Barnett, C.R.; Gibson, G.G.; Wolf, C.R.; Flatt, P.R. and Ioannides, C. (1990) Biochem. J., 268(3), 765-769.
66. Donahue, B.S.; Skottner-Lundin, A. and Morgan, E.T. (1991) Endocrinology, 128(4), 2065-2076.
67. Shimojo, N.; Ishizaki, T.; Imaoka, S.; Funae, Y.; Fujii, S. and Okuda, K. (1993) Biochem. Pharmacol., 46(4), 621-627.
68. Stewart, C.C. and Strother, A. (1999) Life Sci., 64(23), 2163-2172.
69. Matzke, G.R.; Frye, R.F.; Early, J.J.; Straka, R.J. and Carson, S.W. (2000) Pharmacotherapy, 20(2), 182-190.
70. Sotaniemi, E.A.; Pelkonen, O.; Arranto, A.J.; Tapanainen, P.; Rautio, A. and Pasanen, M. (2002) Pharmacol. Toxicol., 90(3), 155-160.
71. Reimann, I.R.; Schilbach, S.; Cercasov, M. and Hoffmann, A. (2001) Int. J. Clin. Pharmacol. Ther., 39(11), 499-502.
72. Pi-Sunyer, F.X. (2002) Obes. Res., 10(Suppl 2), 97S-104S.
73. Bray, G.A. (2003) Endocrinol. Metab. Clin. North Am., 32(4), 787-804.
74. Quesenberry, C.P. Jr.; Caan, B. and Jacobson, A. (1998) Arch. Intern. Med., 158(5), 466-472.
75. Raucy, J.L.; Lasker, J.M.; Kraner, J.C.; Salazar, D.E.; Lieber, C.S. and Corcoran, G.B. (1991) Mol. Pharmacol., 39(3), 275-280.
76. Bandyopadhyay, A.M.; Chaudhary, I.; Robertson, L.W.; Gemzik, B.; Parkinson, A. and Blouin, R.A. (1993) Arch. Biochem. Biophys., 307(2), 386-390.
77. Zannikos, P.N.; Bandyopadhyay, A.M.; Robertson, L.W. and Blouin, R.A. (1994) Int. J. Obes. Relat. Metab. Disord., 18(6), 369-374.
78. Roe, A.L.; Howard, G.; Blouin, R. and Snawder, J.E. (1999) Int. J. Obes. Relat. Metab. Disord., 23(1), 48-53.
79. Watson, A.M.; Poloyac, S.M.; Howard, G. and Blouin, R.A. (1999) Drug Metab. Dispos., 27(6), 695-700.
80. Kotlyar, M. and Carson, S.W. (1999) Int. J. Clin. Pharmacol. Ther., 37(1), 8-19.
81. Leakey, J.E.; Cunny, H.C.; Bazare, J. Jr.; Webb, P.J.; Feuers, R.J.; Duffy, P.H. and Hart, R.W. (1989) Mech. Ageing Dev., 48(2), 145-155.
82. Tu, Y.Y. and Yang, C.S. (1983) Cancer Res., 43(2), 623-629.
83. Hong, J.Y.; Pan, J.M.; Gonzalez, F.J.; Gelboin, H.V. and Yang, C.S. (1987) Biochem. Biophys. Res. Commun., 142(3), 1077-1083.
84. Brown, B.L.; Allis, J.W.; Simmons, J.E. and House, D.E. (1995) Toxicol. Lett., 81(1), 39-44.
85. Hu, Y.; Ingelman-Sundberg, M. and Lindros, K.O. (1995) Biochem. Pharmacol., 50(2), 155-161.
86. Ronis, M.J.; Huang, J.; Longo, V.; Tindberg, N.; Ingelman-Sundberg, M. and Badger, T.M. (1998) Biochem. Pharmacol., 55(2), 123-129.
87. Martini, R.; Butler, A.M.; Jiang, X.M. and Murray, M. (1995) J. Pharmacol. Exp. Ther., 273(1), 427-434.
88. Murray, M.; Sefton, R.M.; Croft, K.D. and Butler, A.M. (2001) Br. J. Pharmacol., 34(7), 1487-1497.
89. Yamazaki, H. and Shimada, T. (1999) Xenobiolica, 29(3), 231-241.
90. Klinger, W.; Karge, E.; Danz, M. and Krug, M. (1995) Exp. Toxicol. Pathol., 47(4), 299-304.
91. McGiff, J.C. (1991) Annu. Rev. Pharmacol. Toxicol., 31, 339-369.
92. Schwartzman, M.L.; Abraham, N.G.; Carroll, M.A.; Levere, R.D. and McGiff, J.C. (1986) Biochem. J., 238(1), 283-290.
93. Oyekan, A.O.; Youseff, T.; Fulton, D.; Quilley, J. and McGiff J.C. (1999) J. Chn. Invest., 104(8), 1131-1137.
94. Zhao, X.; Pollock, D.M.; Inscho, E.W.; Zeldin, D.C. and Imig, J.D. (2003) Hypertension, 41(3 Pt 2), 709-714.
95. Darbar, D.; Dell'Orto, S.; Morike, K.; Wilkinson, G.R. and Roden, D.M. (1997) Clin. Pharmacol. Ther., 61(3), 292-300.
96. Kihara, T.; Toda, A.; Umesue, I.; Ono, N.; Shigematsu, H.; Soeda, S. and Shimeno, H. (1998) Xenobiotica, 28(6), 559-569.
97. Sheweita, S.A.; Mubark, J.; Doenhofe, M.J.; Mostafa, M.H.; Margison, G.P.; O'Connor, P.J. and Elder, R. H. (2002) J. Helminthol., 76(1), 71-78.
98. Cui, X.; Kalsotra, A.; Robida, A.M.; Matzilevich, D.; Moore, A.N.; Boehme, C.L.; Morgan, E.T.; Dash, P.K. and Strobel, H.W. (2003) Biochim. Biophys. Acta, 1619(3), 325-331.
99. Khatsenko, O. and Kikkawa, Y. (1997) J. Pharmacol. Exp. Ther., 280(3), 1463-1470.
100. Li-Masters, T. and Morgan, E.T. (2001) Drug Metab. Dispos., 29(3), 252-257.
101. Renton, K.W. and Nicholson, T.E. (2000) J. Pharmacol. Exp. Ther., 294(2), 524-530.
102. McCann, S.M.; Kimura, M.; Karanth, S.; Yu, W.H.; Mastronardi, C.A. and Rettori, V. (2000) Ann. N. Y. Acad. Sci., 917, 4-18.
103. Papanicolaou, D.A. (2000) Rev. Endocr. Metab. Disord., 1(1-2), 43-48.
104. Tsigos, C.; Chrousos, G.P. (2002) J. Psychosom. Res., 53(4), 865-871.
105. Kalra, P.S.; Edwards, T.G.; Xu, B.; Jain, M.; Kalra, S.P. (1998) Domest. Anim. Endocrinol., 15(5), 321-332.
106. Shedlofsky, S.I.; Israel, B.C.; Tosheva, R. and Blouin, R.A. (1997) Br. J. Clin. Pharmacol., 43(6), 627-632.
107. Danielson, P.B. (2003) Curr. Drug Metab., 3(6), 561-597.
108. Nelson, D.R.; Zeldin, D.C.; Hoffman, S.M.; Maltais, L.J.; Wain, H.M. and Nebert, D.W. (2004) Pharmacogenetics, 14(1), 1-18.